Health And Medicine
-
Ren’s lab advances SARS-CoV-2 research and prioritizes safety during Research Ramp-up
Assistant Professor of Biochemistry Yi Ren and her team have made several discoveries to illuminate the mechanisms of key host-pathogen interactions involving viruses, with implications for gaining a better understanding of SARS-CoV-2, the virus that causes COVID-19. Read MoreNov 6, 2020
-
Nancy Carrasco’s pioneering public health work recognized with National Academy of Medicine election
Nancy Carrasco, professor and chair of the Department of Molecular Physiology and Biophysics and the Joe C. Davis Chair of Biomedical Science, receives one of the highest honors in health and medicine. Read MoreNov 4, 2020
-
Velma McBride Murry’s pathbreaking family intervention work recognized with National Academy of Medicine election
Velma McBride Murry, University Professor of Health Policy and Human & Organizational Development, receives one of the highest honors in health and medicine. Read MoreNov 4, 2020
-
Spontaneous release of neurotransmitters in the brain identified as a culprit of developmental disorders in infants and children
Vanderbilt researchers discover how a group of neurodevelopmental disorders ranging in severity are caused in infants and children, opening new avenues for therapeutics. Read MoreNov 3, 2020
-
Jerri Rook is awarded the Alzheimer’s Drug Discovery Foundation’s prestigious Melvin R. Goodes prize
Behavioral and systems neuropharmacologist Jerri Rook is recognized by the Alzheimer’s Drug Discovery Foundation with the Goodes Prize to continue her work in Alzheimer’s disease research. Read MoreNov 2, 2020
-
Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment
Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases. Read MoreOct 27, 2020
-
Vanderbilt biochemists reveal the cause of Charcot-Marie-Tooth disease—too much of a good thing
Vanderbilt researchers—including Charles Sanders, associate dean for research and professor of biochemistry, and graduate student Justin Marinko—have illuminated the cause of Charcot-Marie-Tooth disease, putting them on the road to developing therapeutic approaches for the disease that affects one in 2,500 people. Read MoreOct 27, 2020
-
School of Nursing receives $3.2 million HRSA grant to increase diversity in health care
Vanderbilt University School of Nursing will use a $3.2 million federal grant for a scholarship program for economically disadvantaged students from underrepresented racial and ethnic minority backgrounds. The program aims to increase diversity in primary health care providers, particularly in medically underserved areas. Read MoreOct 21, 2020
-
Interdisciplinary melanoma research brings understanding of cellular resistance to cancer treatment, opening doors to new cures
Drug-tolerant persister cells–those that survive cancer treatment–found to rely on similar survival mechanisms across cancers, in a groundbreaking study led by Vanderbilt researchers. Read MoreOct 21, 2020
-
Warren Center for Neuroscience Drug Discovery names Craig Lindsley as director
Craig Lindsley, the William K. Warren, Jr. Chair and University Professor of Pharmacology, Biochemistry and Chemistry, will become director of Vanderbilt University’s Warren Center for Neuroscience Drug Discovery, effective Dec. 1, 2020. Read MoreOct 20, 2020
-
Three from Vanderbilt elected to the National Academy of Medicine
Three Vanderbilt faculty members—Nancy Carrasco, Velma McBride Murry and Consuelo Wilkins—have been elected this year to the National Academy of Medicine, the organization announced on Monday. Read MoreOct 20, 2020
-
Vanderbilt researchers make counterintuitive discoveries about immune-like characteristics of cells, chemotherapy’s impact on tissue growth
Biologists reveal that tissue perturbations by chemotherapy agents promote stem cell expansion and that fibroblast cells exhibit unexpected, immune-like behavior. Read MoreOct 15, 2020
-
AI-based tech to improve stroke outcomes
Two prototype devices could refine thrombectomy through sensory augmentation. Read MoreOct 14, 2020
-
Vanderbilt researchers develop publicly available COVID-19 animal susceptibility prediction tool; suggests increased risk to horses
All-remote collaboration results in free animal susceptibility tool to help prioritize research and closer examination of at-risk species. Read MoreOct 6, 2020
-
Nominations sought for 2021 Vanderbilt Prize in Biomedical Science
Nominations for the 2021 Vanderbilt Prize in Biomedical Science are now being accepted. The nomination deadline is Dec. 11. Read MoreOct 5, 2020
-
Grant from Google to support COVID gene expression study
Vanderbilt researchers have been awarded $500,000 by Google’s philanthropic arm, Google.org, to study how COVID-19 alters gene expression in some people in ways that may be linked to to their risk of severe illness and death. Read MoreSep 22, 2020
-
Study identifies antibodies that block alphaviruses
Researchers at Vanderbilt University Medical Center have identified antibodies that, in animals, block infection by alphaviruses, which can cause chronic and debilitating joint pain and arthritis and are an increasing global health concern. Read MoreSep 20, 2020
-
VUMC awarded $34 million to lead nationwide convalescent plasma study
Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19. Read MoreSep 20, 2020
-
‘Scavenger’ molecule may point to new atherosclerosis treatment
A small-molecule “scavenger” that reduces inflammation and formation of atherosclerotic plaque in blood vessels in mice potentially could lead to a new approach for treating atherosclerosis in humans, according to researchers at Vanderbilt University Medical Center. Read MoreSep 20, 2020
-
International collaboration with Vanderbilt scientists sheds light on rare exocyst mutations that cause severe developmental disabilities in children
Mukhtar Ahmed, Christian de Caestecker and Ian Macara, in collaboration with geneticists from Australia and Italy discover novel mutations in the Exocyst, providing new understanding of a critical cellular protein complex. Read MoreSep 14, 2020